Structure |
Chemical Name |
CAS |
MF |
|
Engelide intermediate |
|
|
|
tert-butyl 2-cyanoazetidine-1-carboxylate |
887588-82-1 |
C9H14N2O2 |
|
(1R)-(+)-TRANS-PINANE |
4863-59-6 |
C10H18 |
|
1-tert-Butyl2-methyl3-oxopyrrolidine-1,2-dicarboxylate |
130948-04-8 |
C11H17NO5 |
|
Cefiderocol |
1225208-94-5 |
C30H34ClN7O10S2 |
|
2,3-Dimethylbenzyl alcohol |
13651-14-4 |
C9H12O |
|
N-((3R,4R)-1-benzyl-4-Methylpiperidin-3-yl)-N-Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-aMine |
1702274-61-0 |
C20H25N5 |
|
tert-butyl 4-(2,2,2-trifluoroethyl)piperazine-1-carboxylate |
692058-21-2 |
C11H19F3N2O2 |
|
Intermediate of Rolapitant |
552293-34-2 |
C30H27F6NO3 |
|
Coumarin |
15938-72-4 |
C28H22O9 |
|
1-BOC-3,5-DIMETHYL-PIPERAZINE |
129779-30-2 |
C11H22N2O2 |
|
10-Hydroxybenzo[h]quinoline |
33155-90-7 |
C13H9NO |
|
(7alpha,17beta)-17-(Acetyloxy)-7-[9-[(4,4,5,5,5-pentafluoropentyl)thio]nonyl]estr-4-en-3-one |
415927-29-6 |
C34H51F5O3S |
|
(2-Chloro-5-iodophenyl)[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]methanone |
915095-87-3 |
C17H14ClIO3 |
|
5-(2-fluorophenyl)-1H-pyrrole-3-carbonitrile |
1240948-77-9 |
C11H7FN2 |
|
5-Bromo-2-methylbenzoic acid |
79669-49-1 |
C8H7BrO2 |
|
4-fluoro-2-Methoxy-5-nitroaniline |
1075705-01-9 |
C7H7FN2O3 |
|
EthanediaMide iMpurity F hcl |
482375-18-8 |
C2H4N2O2 |
|
BENZYL 3-HYDROXYAZETIDINE-1-CARBOXYLATE |
128117-22-6 |
C11H13NO3 |
|
7-amino-3-phenyl-2-benzopyrone |
4108-61-6 |
C15H11NO2 |
|
4-(difluoromethyl)pyrimidin-2-amine |
1780891-13-5 |
C5H5F2N3 |
|
4-Methylcumarin |
607-71-6 |
C10H8O2 |
|
Dabigatran intermediate |
|
|
|
2,2-Bis(3-amino-4-hydroxyphenyl)propane |
1220-78-6 |
C15H18N2O2 |
|
7-chloro-1H-imidazo[4,5-b]pyridine |
6980-11-6 |
C6H4ClN3 |
|
Silicone intermediate |
|
|
|
5-Chlorothiophene-2-ylmethanol |
74168-69-7 |
C5H5ClOS |
|
2,3,3-Trimethyl-3H-indole-5-sulfonic acid |
132557-72-3 |
C11H13NO3S |
|
1-cyclopropyl-7-(2,8-diazabicyclo[4.3.0]non-8-yl)-6-fluoro-8-methoxy-4 -oxo-quinoline-3-carboxylic acid |
354812-41-2 |
C21H24FN3O4 |
|
1-fluoropyridine trifluoromethyl sulfonate |
|
|
|
4-METHOXY-1H-INDAZOL-3-AMINE |
886362-07-8 |
C8H9N3O |
|
NALPHA-9-Fluorenylmethoxycarbonyl-L-leucine N-carboxylic anhydride |
125814-21-3 |
C22H21NO5 |
|
BORTEZOMIB-PINANEDIOL |
205393-22-2 |
C29H39BN4O4 |
|
7-bromo-[1,2,4]triazolo[1,5-a]pyridin-2-amine |
882521-63-3 |
C6H5BrN4 |
|
4-AMINO-CHROMEN-2-ONE |
53348-92-8 |
C9H7NO2 |
|
5'-O-(4,4-Dimethoxytrityl)-2'-O-[(tert-butyl)dimethylsilyl]-N-isobutyrylguanosine-3'-(2-cyanoethyl-N,N-diisopropyl)phosphoramidite |
147201-04-5 |
C50H68N7O9PSi |
|
[402960-19-4],C9H18N2O2, 186.40 |
850252-34-5 |
C9H19ClN2O2 |
|
dibenzo[b,d]thiophene-4-carbaldehyde |
23985-81-1 |
C13H8OS |
|
a-D-Glucopyranoside,methyl 4-O-[2-O-acetyl-6-methyl-3-O-(phenylmethyl)-a-L-idopyranuronosyl]-2-deoxy-2-[[(phenylmethoxy)carbonyl]amino]-3-O-(phenylmethyl)-,6-acetate |
114869-97-5 |
C40H47NO15 |
|
Dimethyl Furan-2,5-dicarboxylate |
4282-32-0 |
C8H8O5 |
|
thiadiazole |
288-48-2 |
C2H2N2S |
|
PROSTAGLANDIN A2 |
13345-50-1 |
C20H30O4 |
|
2,3-DIHYDRO-2-THIOXO-PYRIDO[3,4-D]PYRIMIDIN-4(1H)-ONE |
412341-42-5 |
C7H5N3OS |
|
METHYL 1-BENZYL-4-PHENYLPYRROLIDINE-3-CARBOXYLATE |
438492-33-2 |
C19H21NO2 |
|
1-Methyl-4-[[4-nitro-2-(trifluoromethyl)phenyl]methyl]-piperazine |
694499-24-6 |
C13H16F3N3O2 |
|
(1S,4R)-4-(2-Amino-6-chloro-9H-purin-9-yl)-2-cyclopentene-1-carboxylate |
1246819-78-2 |
C11H10ClN5O2 |
|
benzyl 3,3-difluorocyclobutanecarboxylate |
935273-86-2 |
C12H12F2O2 |
|
4-(hidroximetil)-5-metil-1,3-dioxol-2-one |
91526-18-0 |
C5H6O4 |
|
Paliperidone Palmitate |
199739-10-1 |
C39H57FN4O4 |
|
Methyl 2-hydroxy-5-methyl-3-nitrobenzenecarboxylate |
67191-44-0 |
C9H9NO5 |
|
8-Benzyloxy-5-((R)-2-broMo-1-hydroxyethyl)-1H-quinolinone |
530084-79-8 |
C18H16BrNO3 |
|
RebaMipide interMediate product |
169809-59-0 |
C19H16ClN2NaO4 |
|
ethyl 7-chloro-1,4-dihydro-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylate, 7-chloro-1,4-dihydro-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid ethyl ester |
174726-87-5 |
C14H10ClN3O3S |
|
3-(aMinoMethyl)-4,6-diMethyl-1,2-dihydropyridin-2-one hydrochloride |
1173081-96-3 |
C8H13ClN2O |
|
5-isothiocyanato-3-(trifluoromethyl)picolinonitrile |
951753-87-0 |
C8H2F3N3S |
|
5,7-Dichloro-1,2,3,4-Tetrahydroisoquinoline-6-Carboxylic Acid Hydrochloride |
1289646-93-0 |
C10H10Cl3NO2 |
|
tert-butyl (5S,8S,11S,12R)-11-((S)-sec-butyl)-1-(9H-fluoren-9-yl)-5,8-diisopropyl-12-methoxy-4,10-dimethyl-3,6,9-trioxo-2-oxa-4,7,10-triazatetradecan-14-oate |
474645-25-5 |
C40H59N3O7 |
|
2'-CHLORO-2'-DEOXYURIDINE |
4753-04-2 |
C9H11ClN2O5 |
|
dimethyl 6,7-dihydro-5H-pyrrolizine-1,2-dicarboxylate |
62563-06-8 |
C11H13NO4 |
|
13,14-DIHYDRO-15-KETO PROSTAGLANDIN F2ALPHA |
27376-76-7 |
C20H34O5 |
|
1,3-DIMETHYL-2'-DEOXYPSEUDOURIDINE |
65358-16-9 |
C11H16N2O5 |
|
3-amino-5,7-dimethyl-2H-pyrazolo[3,4-d]pyrimidine-4,6-dione |
67304-67-0 |
C7H9N5O2 |
|
4,7-DIMETHYLCOUMARIN |
14002-90-5 |
C11H10O2 |
|
5-Fluoroindole |
399-52-0 |
C8H6FN |
|
N-(8-Amino-6-fluoro-5-methyl-1-oxo-1,2,3,4-tetrahydronaphthalen-2-yl)acetamide |
182182-31-6 |
C13H15FN2O2 |
|
5-BRDU 5-bromo-2'-deoxyuridine |
|
|
|
Material intermediate |
75286-83-8 |
C52H38N4O8 |
|
4-methyl-7-nitro- 2H-chromen-2-one |
179897-88-2 |
C10H7NO4 |
|
Cefradine double nucleus |
|
|
|
2,2'-[9H-Fluoren-9-ylidenebis(4,1-phenyleneoxymethylene)]bis-oxirane |
47758-37-2 |
C31H26O4 |
|
Medicinal hollow capsule |
|
|
|
5-(Difluoromethoxy)-2-mercapto-1H-benzimidazole |
97963-62-7 |
C8H6F2N2OS |
|
ADENYLYL(3'>5')CYTIDINE FREE ACID |
2382-66-3 |
C19H25N8O11P |
|
1,4-PIPERAZINEDICARBONYL CHLORIDE |
4858-84-8 |
C6H8Cl2N2O2 |
|
2 3-DIBROMOBENZO(B)THIOPHENE 97 |
6287-82-7 |
C8H4Br2S |
|
CEFMETAZOLE MMT ISOMER |
|
|
|
1,4-Piperazinedicarboxylic acid, 2-(hydroxymethyl)-, 1-(1,1-dimethylethyl) 4-(phenylmethyl) ester, (2S)- |
385802-84-6 |
C18H26N2O5 |
|
Cyclobutanecarboxylic acid, 3-(methylamino)-, 1-methylethyl ester, cis- |
2136718-64-2 |
C9H17NO2 |
|
NA |
|
|
|
(2R)-methyl 8-methyl-3-oxo-8-azabicyclo[3.2.1]octane-2-carboxylate |
85506-18-9 |
C10H15NO3 |
|
Cefminox for system suitability |
|
|
|
(S)-2-((trifluoromethoxy)methyl)piperazine dihydrochloride |
|
|
|
Flomoxef Intermediate NaMT |
|
|
|
4-(4-NITROPHENYL)MORPHOLIN-3-ONE |
446292-04-2 |
C10H10N2O4 |
|
2-METHANESULFONYL-PYRIMIDINE |
14161-09-2 |
C5H6N2O2S |
|
3,4-(Methylenedioxy)aniline |
14268-66-7 |
C7H7NO2 |
|
8-OXO-DG |
|
|
|
(3S,4R,5R)-Oseltamivir |
|
|
|
4-Benzo[b]thien-2-ylbenzenamine |
54492-95-4 |
C14H11NS |
|
TERT-BUTYL (4-OXOCYCLOHEXYL) METHYLCARBAMATE |
809273-70-9 |
C12H21NO3 |
|
2-[4-[(1-methoxycarbonyl-2-oxocyclopentyl)methyl]phenyl]propanoic acid |
|
|
|
4-HYDROXY-2-METHYLPYRIMIDINE-5-CARBOXYLIC ACID |
18529-69-6 |
C6H6N2O3 |
|
methyl ibogamine-18-carboxylate |
467-77-6 |
C21H26N2O2 |
|
4,6-dimethoxy-2-methyl-5-nitropyrimidine |
29939-34-2 |
C7H9N3O4 |
|
INTERMEDIATES |
1243021-74-0 |
C13H26N2O5 |
|
ethyl 8-chloro-1-cyclopropyl-6,7-difluoro-1,4-dihydroquinoline-4-oxo-3-carboxyla |
99696-21-6 |
C15H12ClF2NO3 |
|
(R)-(+)-Etomoxir sodium salt |
828934-41-4 |
C15H20ClNaO4 |
|
2'-DEOXYCYTIDINE MONOHYDRATE, 99+% |
652157-52-3 |
C9H15N3O5 |
|
1-Piperidinecarboxylic acid, 4-[4-[(2,6-dioxo-3-piperidinyl)amino]phenyl]-, 1,1-dimethylethyl ester |
2259851-32-4 |
C21H29N3O4 |
|
tert-butyl (3R,6S)-3-((tert-butoxycarbonyl)((tert-butyldimethylsilyl)oxy)amino) -6-carbamoyl -5-methyl-3,6-dihydropyridine-1(2H)-carboxylate |
2209874-00-8 |
C23H43N3O6Si |